OXFORD, England, July 28, 2016 /PRNewswire/ --
- Educational materials provide information for individuals with diabetes on managing their injection routine, increasing awareness of the potential risk of pen needle reuse
- Tailored to support HCPs to better engage with multiple audiences including; adults with Type 1 diabetes and Type 2 diabetes; teenagers with Type 1 diabetes; children with Type 1 diabetes; and pregnant women with gestational diabetes
Owen Mumford, a global industry leader in medical device design and manufacturing, today unveils its new range of educational materials aimed at supporting diabetes self-management and empowering patients to follow a good injection routine. The materials have been developed to provide Healthcare Professionals (HCPs) with a suite of booklets to support education and understanding of the benefits of a good injection routine through frequent needle change.
Cecilia Mendy, Group Brand Manager at Owen Mumford comments, "We're really excited to be launching these new materials which will be available for download on our UK website. As a medical device manufacturer, this is all part of us taking a more patient-centric approach through listening and talking to patients to better understand their needs. Our objective was to communicate a complex topic through simple and attractive imagery to help HCPs engage their patients when talking to them about the importance of pen needle changing behaviour and a good injection routine. These materials follow on from the launch of our Unifine® Pentips® Plus pen needle, which is designed to encourage more frequent needle change. In a user study, Unifine® Pentips® Plus has proven to increase the rate of pen needle change by 61 per cent among people using injection pens to control their diabetes.
Mendy continues, "When using injection pens for diabetes management, it's important for a patient to change their pen needle after each injection. Re-using a pen needle can result in multiple problems including; painful injection sites; an increased risk of lipohypertrophy and lipodystrophy; and inaccurate medication dosage delivery, which can lead to poor glycaemic control,. We hope this educational material will help HCP's and support them in communicating the importance of pen needle change in a well managed injection routine."
Divided up into different audience groups including; adults with type 1 diabetes and type 2 diabetes; teenagers with type 1 diabetes; children with type 1 diabetes; and pregnant women with gestational diabetes, the materials have been created to help HCPs engage with materials that are attractive to each of these distinct patient groupings.
These leaflets are already being offered by our UK team to support our customers and an Advanced Nurse in Diabetes at Argyll and Bute NHS Highland commented, "These booklets on injection routines are easy to read and understand, and the pictures showing how the needles can bend and break will really help patients understand why it is essential to use a needle only once.
Having access to several different booklets which cover all the differing age groups, as well as pregnancy, will be a really useful addition to the information we can give to patients on a day to day basis. As well as this I would definitely use these booklets for patients attending structured education programmes."
The materials are now available online at http://www.owenmumford.com in the diabetes resource centre - a section dedicated to providing resources for people either managing their own diabetes or supporting someone with diabetes. You can also find more information on Unifine® Pentips® plus and its benefits.
Notes to editors
- Impact of Unifine® Pentips® Plus on pen needle changing behaviour amongst people with diabetes medicating with injectable formats [online] - http://www.owenmumford.com/en/wp-content/uploads/sites/2/2014/12/UPP-White-Paper.pdf
- I.V. Miniskova et al. The risk of repeated use of insulin pen needles in patients with diabetes mellitus. Journal of Diabetology, February 2011; 1:1.
- King L (2003) Subcutaneous insulin injection technique. Nursing Standard. 17, 34, 45-52
About Owen Mumford
Owen Mumford is a leading medical device manufacturer that develops pioneering medical devices for its own Owen Mumford brand and custom device solutions for the world's major pharmaceutical and diagnostic companies. Owen Mumford's goal is to improve quality of life, encourage adherence to treatment and reduce healthcare costs. Making a world of difference, to a world of people.
SOURCE Owen Mumford